Compounds > 3,4-dihydro-2(1h)-quinolinone
Page last updated: 2024-08-24

3,4-dihydro-2(1h)-quinolinone and Parkinson Disease

3,4-dihydro-2(1h)-quinolinone has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meiring, L; Petzer, A; Petzer, JP1

Other Studies

1 other study(ies) available for 3,4-dihydro-2(1h)-quinolinone and Parkinson Disease

ArticleYear
C6- and C7-Substituted 3,4-dihydro-2(1H)-quinolinones as Inhibitors of Monoamine Oxidase.
    Drug research, 2017, Volume: 67, Issue:3

    Topics: Humans; Hydroquinones; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Protein Binding; Structure-Activity Relationship

2017